Related Experiment Video
Updated: Feb 15, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Pulmonary vascular development in congenital diaphragmatic hernia
Daphne S Mous1, Heleen M Kool1, Rene Wijnen1
1Dept of Pediatric Surgery, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
Congenital diaphragmatic hernia (CDH) involves a diaphragm defect and lung issues, primarily causing persistent pulmonary hypertension (PH). Understanding molecular pathways in pulmonary vascular development is key to new therapeutic approaches for this severe condition.
Area of Science:
- Developmental Biology
- Pediatric Surgery
- Cardiovascular Research
Background:
- Congenital diaphragmatic hernia (CDH) is a complex congenital anomaly.
- It presents with a diaphragmatic defect, lung hypoplasia, and persistent pulmonary hypertension (PH).
- PH is the primary cause of mortality in affected newborns, with limited evidence-based treatments.
Purpose of the Study:
- To provide an overview of molecular pathways in pulmonary vascular development.
- To describe vascular abnormalities in CDH.
- To explore potential therapeutic strategies for CDH.
Main Methods:
- Review of current literature on pulmonary vascular development.
- Analysis of molecular pathways involved in vascular growth.
- Examination of CDH-associated vascular defects.
Main Results:
- Pulmonary vascular development is intrinsically linked to airway epithelial development.
- Abnormalities in vascular development originate early in gestation.
- Increased arteriolar and capillary muscularization characterizes PH in CDH.
Conclusions:
- Early disturbances in pulmonary vascular development lead to significant growth abnormalities in CDH.
- Further understanding of molecular pathways is crucial for developing effective therapies.
- Targeting molecular pathways offers potential for improved treatment of CDH and its associated PH.
More Related Videos
Related Concept Videos
Seedless Vascular Plants
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Vascular Spasm
Overview of the Vascular System

